Several recent studies have integrated TF binding site or occupancy data to identify cancer-associated TFs, for example, combining tumour-specific DNA methylation changes in distal enhancers, mRNA sequencing and cis-regulatory sequences mediating effects on target genes71 or integrating ENCODE TF ChIP-seq profiles with the pancancer TCGA expression data72. Here, TF is linked to cancer.